Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001842379 | SCV001341294 | uncertain significance | Cardiac arrhythmia | 2023-05-15 | criteria provided, single submitter | clinical testing | This missense variant replaces proline with leucine at codon 1725 of the SCN5A protein. Computational prediction suggests that this variant may have a deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individuals affected with Brugada syndrome (PMID: 26173111, 32268277, DOI:10.1186/s42444-022-00077-9). It has also been reported in an individual affected with long QT syndrome (PMID: 19862833). This variant has been identified in 5/251170 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Labcorp Genetics |
RCV001529380 | SCV002192078 | uncertain significance | not provided | 2023-12-14 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 1725 of the SCN5A protein (p.Pro1725Leu). This variant is present in population databases (rs199473301, gnomAD 0.01%). This missense change has been observed in individual(s) with SCN5A-related conditions (PMID: 19862833, 26173111). ClinVar contains an entry for this variant (Variation ID: 67962). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
All of Us Research Program, |
RCV001842379 | SCV004827246 | uncertain significance | Cardiac arrhythmia | 2023-11-30 | criteria provided, single submitter | clinical testing | This missense variant replaces proline with leucine at codon 1725 of the SCN5A protein. Computational prediction suggests that this variant may have a deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individuals affected with Brugada syndrome (PMID: 26173111, 32268277, DOI:10.1186/s42444-022-00077-9). It has also been reported in an individual affected with long QT syndrome (PMID: 19862833). This variant has been identified in 5/251170 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004019059 | SCV004944530 | uncertain significance | Cardiovascular phenotype | 2021-08-09 | criteria provided, single submitter | clinical testing | The c.5174C>T (p.P1725L) alteration is located in exon 28 (coding exon 27) of the SCN5A gene. This alteration results from a C to T substitution at nucleotide position 5174, causing the proline (P) at amino acid position 1725 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Kardio |
RCV004668766 | SCV005094553 | uncertain significance | Dilated cardiomyopathy 1E | 2024-07-03 | criteria provided, single submitter | clinical testing | |
Cardiovascular Biomedical Research Unit, |
RCV000058748 | SCV000090268 | not provided | Congenital long QT syndrome | no assertion provided | literature only | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:19862833). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. | |
Diagnostic Laboratory, |
RCV001529380 | SCV001742723 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001529380 | SCV001958048 | uncertain significance | not provided | no assertion criteria provided | clinical testing |